Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Chopp, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Chopp, M.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction
Neurology 2001;56:1666-1672
© 2001 American Academy of Neurology
Articles

Treatment of stroke in rat with intracarotid administration of marrow stromal cells

Y. Li, MD;, J. Chen, MD;, L. Wang, MD;, M. Lu, PhD; and M. Chopp, PhD

From the Departments of Neurology (Drs. Li, Chen, Wang, and Chopp) and Biostatistics and Research Epidemiology (Dr. Lu), Henry Ford Health Sciences Center, Detroit; and the Department of Physics (Dr. Chopp), Oakland University, Rochester, MI.

Address correspondence and reprint requests to Dr. Michael Chopp, Department of Neurology (E&R3056), Henry Ford Health Sciences Center, 2799 West Grand Boulevard, Detroit, MI 48202; e-mail: chopp{at}neuro.hfh.edu

OBJECTIVE: To measure the therapeutic efficacy for the treatment of stroke with intra-arterial administration of bone marrow stromal cells (MSC).

BACKGROUND: MSC have characteristics of stem and progenitor cells. The hypothesis that MSC injected into the internal carotid artery after stroke enter into ischemic brain and improve neurologic recovery was tested.

METHODS: Twenty-five adult Wistar rats were subjected to transient (2-hour) middle cerebral artery occlusion alone (n = 9), or treated with intracarotid arterial injection of 200 µL phosphate-buffered saline (n = 8) or 2 x 106 MSC in 200 µL phosphate-buffered saline (n = 8) 1 day after ischemia. MSC were harvested and isolated from additional adult rats and then cultured and labeled with bromodeoxyuridine. Rats were subjected to neurologic functional tests (adhesive-removal, modified neurologic severity scores) before and at 1, 7, and 14 days after middle cerebral artery occlusion. Immunohistochemistry was used to identify cell-specific proteins of bromodeoxyuridine-reactive MSC.

RESULTS: Bromodeoxyuridine-reactive cells (~21% of 2 x 106 injected MSC) distributed throughout the territory of the middle cerebral artery by 14 days after ischemia. Some bromodeoxyuridine-reactive cells expressed proteins characteristic of astrocytes and neurons. Rats with intra-arterial transplantation of MSC exhibited improvement on the adhesive-removal test (p < 0.05) and the modified neurologic severity scores (p < 0.05) at 14 days compared with controls.

CONCLUSIONS: MSC injected intra-arterially are localized and directed to the territory of the middle cerebral artery, and these cells foster functional improvement after cerebral ischemia.




This article has been cited by other articles:


Home page
 StrokeHome page
S. Schwarting, S. Litwak, W. Hao, M. Bahr, J. Weise, and H. Neumann
Hematopoietic Stem Cells Reduce Postischemic Inflammation and Ameliorate Ischemic Brain Injury
Stroke, October 1, 2008; 39(10): 2867 - 2875.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Iwanami, M. Mogi, J.-M. Li, K. Tsukuda, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi
Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia-Reperfusion Brain Injury in Mice * Supplemental Materials and Methods
Stroke, September 1, 2008; 39(9): 2554 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S.-S. Kim, S.-W. Yoo, T.-S. Park, S.-C. Ahn, H.-S. Jeong, J.-W. Kim, D.-Y. Chang, K.-G. Cho, S. U. Kim, Y. Huh, et al.
Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain
Stem Cells, September 1, 2008; 26(9): 2217 - 2228.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C.M. van Zijl, J. Huang, and J. W.M. Bulte
Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia
Stroke, May 1, 2008; 39(5): 1569 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. Buhnemann, A. Scholz, C. Bernreuther, C. Y. Malik, H. Braun, M. Schachner, K. G. Reymann, and M. Dihne
Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats
Brain, December 1, 2006; 129(12): 3238 - 3248.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. Liu, O. Honmou, K. Harada, K. Nakamura, K. Houkin, H. Hamada, and J. D. Kocsis
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
Brain, October 1, 2006; 129(10): 2734 - 2745.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
E. Dalakas, P. N. Newsome, D. J. Harrison, and J. N. Plevris
Hematopoietic stem cell trafficking in liver injury
FASEB J, August 1, 2005; 19(10): 1225 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
O. Lindvall and Z. Kokaia
Recovery and Rehabilitation in Stroke: Stem Cells
Stroke, November 1, 2004; 35(11_suppl_1): 2691 - 2694.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S.-W. Jeong, K. Chu, K.-H. Jung, S. U. Kim, M. Kim, and J.-K. Roh
Human Neural Stem Cell Transplantation Promotes Functional Recovery in Rats With Experimental Intracerebral Hemorrhage
Stroke, September 1, 2003; 34(9): 2258 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. T. Suratt, C. D. Cool, A. E. Serls, L. Chen, M. Varella-Garcia, E. J. Shpall, K. K. Brown, and G. S. Worthen
Human Pulmonary Chimerism after Hematopoietic Stem Cell Transplantation
Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 318 - 322.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Howells
Stem Cells: Do They Replace or Stimulate?
Stroke, August 1, 2003; 34(8): 2082 - 2083.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Chen, Z. G. Zhang, Y. Li, L. Wang, Y. X. Xu, S. C. Gautam, M. Lu, Z. Zhu, and M. Chopp
Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats
Circ. Res., April 4, 2003; 92(6): 692 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Sun, K. Jin, A. Peel, X. O. Mao, L. Xie, and D. A. Greenberg
Neuroglobin protects the brain from experimental stroke invivo
PNAS, March 18, 2003; 100(6): 3497 - 3500.
[Abstract] [Full Text] [PDF]

Home page
 Sci Aging Knowl EnvironHome page
J. M. Edelberg
Auto Repair on the Aging Stem Cell Superhighway
Sci. Aging Knowl. Environ., September 4, 2002; 2002(35): pe13 - 13.
[Abstract] [Full Text]

Home page
 StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Korbling, R. L. Katz, A. Khanna, A. C. Ruifrok, G. Rondon, M. Albitar, R. E. Champlin, and Z. Estrov
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells
N. Engl. J. Med., March 7, 2002; 346(10): 738 - 746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.